Wine, Alcohol, and Cardiovascular Health: Revisiting the Health Benefits of Wine in the Framingham Heart Study. Michael Darden and Douglas Nelson
|
|
- Darleen Walters
- 5 years ago
- Views:
Transcription
1 Wine Alcohol and Cardiovascular Health: Revisiting the Health Benefits of Wine in the Framingham Heart Study. Michael Darden and Douglas Nelson May 28th 2015
2 Outline Background Our Approach Framingham Heart Study Descriptive Analysis Application - Smoking AWEA Wine and Health 05/28/2015 2
3 Does Everything We Consume Cause Cancer? AWEA Wine and Health 05/28/2015 3
4 Does Everything We Consume Cause Cancer? AWEA Wine and Health 05/28/2015 3
5 Why is it difficult? Assessing the long-term health effects of alcohol consumption is difficult because: AWEA Wine and Health 05/28/2015 4
6 Why is it difficult? Assessing the long-term health effects of alcohol consumption is difficult because: 1. Many major health outcomes occur far in the future. AWEA Wine and Health 05/28/2015 4
7 Why is it difficult? Assessing the long-term health effects of alcohol consumption is difficult because: 1. Many major health outcomes occur far in the future. 2. Ideally the difference in major health outcomes should be calculated from observed health differences following random assignment of lifetime drinking behavior. AWEA Wine and Health 05/28/2015 4
8 Why is it difficult? Assessing the long-term health effects of alcohol consumption is difficult because: 1. Many major health outcomes occur far in the future. 2. Ideally the difference in major health outcomes should be calculated from observed health differences following random assignment of lifetime drinking behavior. In reality researchers must use observational data. AWEA Wine and Health 05/28/2015 4
9 What is typically done? 1. Difference in Means Simple and transparent Ignores potential heterogeneity AWEA Wine and Health 05/28/2015 5
10 What is typically done? 1. Difference in Means Simple and transparent Ignores potential heterogeneity For example: Doll et al British Medical Journal study the effect of smoking on expected longevity AWEA Wine and Health 05/28/2015 5
11 What is typically done? 1. Difference in Means Simple and transparent Ignores potential heterogeneity For example: Doll et al British Medical Journal study the effect of smoking on expected longevity Confounding factors are unlikely to have influenced greatly the absolute difference between the overall mortality rates of cigarette smokers and lifelong non-smokers - Doll et al British Medical Journal AWEA Wine and Health 05/28/2015 5
12 What is typically done? 2. Controlling for observed heterogeneity. Conditional estimates of health impact. Biased if unobserved factors influence both lifestyle behavior and health outcomes AWEA Wine and Health 05/28/2015 6
13 What is typically done? 2. Controlling for observed heterogeneity. Conditional estimates of health impact. Biased if unobserved factors influence both lifestyle behavior and health outcomes For example: Djoussee et al Stroke study the effect of alcohol consumption on the risk of Ischemic Stroke AWEA Wine and Health 05/28/2015 6
14 What is typically done? 2. Controlling for observed heterogeneity. Conditional estimates of health impact. Biased if unobserved factors influence both lifestyle behavior and health outcomes For example: Djoussee et al Stroke study the effect of alcohol consumption on the risk of Ischemic Stroke The full model controlled for age diabetes mellitus(yes/no) smoking categories and body mass index. AWEA Wine and Health 05/28/2015 6
15 Our Approach AWEA Wine and Health 05/28/2015 7
16 Our Approach Consider the following question: How many years of expected longevity are lost from heavy alcohol consumption? AWEA Wine and Health 05/28/2015 7
17 Our Approach Consider the following question: How many years of expected longevity are lost from heavy alcohol consumption? We argue this question is difficult to answer because: 1. Lifetime drinking patterns reflect choices of individuals who differ in observed and unobserved ways. That is alcohol consumption is not random. AWEA Wine and Health 05/28/2015 7
18 Our Approach Consider the following question: How many years of expected longevity are lost from heavy alcohol consumption? We argue this question is difficult to answer because: 1. Lifetime drinking patterns reflect choices of individuals who differ in observed and unobserved ways. That is alcohol consumption is not random. 2. Drinkers and nondrinkers may differ in observed and unobserved ways that contribute to mortality. That is confounding factors influence health outcomes. AWEA Wine and Health 05/28/2015 7
19 Our Approach Consider the following question: How many years of expected longevity are lost from heavy alcohol consumption? We argue this question is difficult to answer because: 1. Lifetime drinking patterns reflect choices of individuals who differ in observed and unobserved ways. That is alcohol consumption is not random. 2. Drinkers and nondrinkers may differ in observed and unobserved ways that contribute to mortality. That is confounding factors influence health outcomes. Because random assignment is not possible we argue that important qualities of observational data should include: A long longtudinal study design. Frequent interviews/exams. Rich observable heterogeneity AWEA Wine and Health 05/28/2015 7
20 Outline Background Our Approach Framingham Heart Study Descriptive Analysis Application - Smoking AWEA Wine and Health 05/28/2015 8
21 The Framingham Heart Study AWEA Wine and Health 05/28/2015 9
22 The Framingham Heart Study The Original Cohort Begun in 1948 to identify the common factors that contribute to cardiovascular disease. Sampled 5209 individuals from Framingham MA and followed them for over 50 years. Detailed health information. Fairly consistent alcohol information. Ages range from 30 to 63 at the initial exam (between 1948 and 1953). The Offspring Cohort: Offspring of the Original Cohort began begin followed in 1971 Sample of 5124 people between ages of 13 and 62 Health examinations/interviews every 2-8 years. AWEA Wine and Health 05/28/2015 9
23 Sample Construction Beer wine and spirits (drinks per week) was recorded at exams: Original Cohort: Offspring Cohort: 1-7 AWEA Wine and Health 05/28/
24 Sample Construction Beer wine and spirits (drinks per week) was recorded at exams: Original Cohort: Offspring Cohort: 1-7 In addition to a variety of biomarkers measured in each exam we have dates for the following health events: Coronary Heart Disease Myocardial Infarction Angina Pectoris Coronary Insufficiency Cerebrovascular Accident Atherothrombotic Infarction Transient Ischemic Attack Cardiovascular Disease Intermittant Claudication Congestive Heart Failure etc. A wide variety of cancers. Death AWEA Wine and Health 05/28/
25 Sample Construction Beer wine and spirits (drinks per week) was recorded at exams: Original Cohort: Offspring Cohort: 1-7 In addition to a variety of biomarkers measured in each exam we have dates for the following health events: Coronary Heart Disease Myocardial Infarction Angina Pectoris Coronary Insufficiency Cerebrovascular Accident Atherothrombotic Infarction Transient Ischemic Attack Cardiovascular Disease Intermittant Claudication Congestive Heart Failure etc. A wide variety of cancers. Death We pool data from both cohorts and after restricting our sample such that a person enters at least twice we have 7454 unique individuals and person/exam observations AWEA Wine and Health 05/28/
26 Table: Summary Statistics - Exogenous Characteristics Original Cohort Offspring Cohort Variable Mean St. Dev Mean St. Dev Female College Age Body Type BMI< BMI [2025) BMI [2529) BMI [3035) BMI> BMI Missing Systolic Blood Pressure Total Cholesterol Missing Currently Smoke Years Smoking AWEA Wine and Health 05/28/
27 Table: Summary Statistics - Alcohol Original Cohort Offspring Cohort Variable Mean St. Dev Mean St. Dev Drinks Wine Glasses/week Drinks Beer Beers/week Drinks Spirits Beers/week AWEA Wine and Health 05/28/
28 Drinks by Age 60 Drinks Alcohol by Type and Age 40 Percent Age Drinks Wine Drinks Spirits Drinks Beer AWEA Wine and Health 05/28/
29 Drinks/Week by Age 10 Drinks per week by Type and Age 8 Drinks/week Age Wine Spirits Beer AWEA Wine and Health 05/28/
30 Original Cohort Health Events 40 Health Events by Observation - Original Cohort 30 Percent Observation Cardiovascular Disease Cancer AWEA Wine and Health 05/28/
31 Offspring Cohort Health Events 15 Health Events by Observation - Offspring Cohort 10 Percent Observation Cardiovascular Disease Cancer AWEA Wine and Health 05/28/
32 Original Cohort Survival Kaplan-Meier Survival Curves - Original Cohort Age Drinker Never Drinker AWEA Wine and Health 05/28/
33 Offspring Cohort Survival Kaplan-Meier Survival Curves - Offspring Cohort Age Drinker Never Drinker AWEA Wine and Health 05/28/
34 Econometric Model Dynamic Panel Data Model. t subscript represents FHS exam time: Dependent Variables: 1. Drinks wine at t 2. Glasses per week drinking wine at t 3. Drinks beer at t 4. Beers per week drinking beer at t 5. Drinks Spirits at t 6. Cocktails per week drinking spirits at t 7. Cardiovascular Disease at t 8. Cancer at t 9. Death at t AWEA Wine and Health 05/28/
35 Econometric Framework AWEA Wine and Health 05/28/
36 Econometric Framework W it = w(a it 1 H it 1 X it P it u w it εw it ) AWEA Wine and Health 05/28/
37 Econometric Framework W it = w(a it 1 H it 1 X it P it u w it εw it ) H it = h(a it H it 1 X it μ h it εh it ) AWEA Wine and Health 05/28/
38 Econometric Framework W it = w(a it 1 H it 1 X it P it u w it εw it ) H it = h(a it H it 1 X it μ h it εh it ) M it = h(a it H it X it μ m it εm it ) AWEA Wine and Health 05/28/
39 Error Structure The error structure for equation j: μ i + ν t + ε it AWEA Wine and Health 05/28/
40 Error Structure The error structure for equation j: μ i + ν t + ε it The distribution of both time-invariant and time-varying unobserved heterogeneity terms μ i and ν t are approximated discretely. We estimate a step function for both: μ i takes A points: (μ 1... μ A ). ν t takes B points: (ν 1... ν B ). Subject to normalizations we estimate these points for each equation as well as the associated probabilities. AWEA Wine and Health 05/28/
41 Model Setup The model captures alcohol and health outcomes for up to 11 periods. Each period of the model is two years in length. W t M t W t 1 H t 1 M t 1 H t AWEA Wine and Health 05/28/
42 Logit Estimator Results Table: Selected Parameter Estimates CVD Cancer Mortality Wine Quartile Relative to No Wine Consumption 1st * (0.112) (0.149) (0.175) 2nd * (0.118) (0.146) (0.178) 3rd (0.099) (0.129) (0.133) 4th (0.120) (0.160) (0.158) Alcohol Quartile Relative to No Alcohol Consumption 1st ** ** (0.063) (0.094) (0.093) 2nd ** ** (0.071) (0.104) (0.108) 3rd ** ** (0.071) (0.105) (0.102) 4th ** ** (0.066) (0.090) (0.098) AWEA Wine and Health 05/28/
43 Simulation Exercise To simulate our model we: 1. Expand each person s observation by 50 AWEA Wine and Health 05/28/
44 Simulation Exercise To simulate our model we: 1. Expand each person s observation by Endow each with random draws from all error terms AWEA Wine and Health 05/28/
45 Simulation Exercise To simulate our model we: 1. Expand each person s observation by Endow each with random draws from all error terms 3. Simulate Behavior while updating state vector. In some cases we impose alcohol consumption and simulate health outcomes. 4. Collapse results by person draw and time. AWEA Wine and Health 05/28/
46 Survival Curves from the Framingham Heart Study Kaplan-Meier Survival Curves: Data Age Smoker Never Smoker Source: Authors Calculations from the Framingham Heart Study AWEA Wine and Health 05/28/
47 Mean Age of Death by Smoking Behavior Mean Age Mean Loss Never Smoker (8.81) - Current Smoker (10.10) AWEA Wine and Health 05/28/
48 Survival Curves from the Framingham Heart Study Kaplan-Meier Survival Curves: Data Age Smoker Never Smoker Source: Authors Calculations from the Framingham Heart Study AWEA Wine and Health 05/28/
49 Simulated Survival Curves by Lifetime Smoking Behavior Kaplan-Meier Survival Curves: Simulation Age Smoker Never Smoker Source: Authors Calculations AWEA Wine and Health 05/28/
50 Simulated Mean Age of Death by Smoking Behavior Mean Age Mean Loss Never Smoker Current Smoker AWEA Wine and Health 05/28/
51 Thank you! AWEA Wine and Health 05/28/
Consumption of different types of alcohol and mortality
Consumption of different types of alcohol and mortality 1 di 6 Results Consumption of different types of alcohol and mortality We know that a moderate amount of alcohol consumption is beneficial for health.
More informationBaldness and Coronary Heart Disease Rates in Men from the Framingham Study
A BRIEF ORIGINAL CONTRIBUTION Baldness and Coronary Heart Disease Rates in Men from the Framingham Study The authors assessed the relation between the extent and progression of baldness and coronary heart
More informationI t is established that regular light to moderate drinking is
32 CARDIOVASCULAR MEDICINE Taking up regular drinking in middle age: effect on major coronary heart disease events and mortality S G Wannamethee, A G Shaper... See end of article for authors affiliations...
More informationTHE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease
THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationAppendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.
Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular
More informationSmoking and Mortality: New Evidence from a Long Panel
Smoking and Mortality: New Evidence from a Long Panel Michael Darden 1, Donna B. Gilleskie 2, and Koleman Strumpf 3 1 Department of Economics, Tulane University 2 Department of Economics, University of
More informationUpdate on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines
Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease
More informationEuroPrevent 2010 Fatal versus total events in risk assessment models
EuroPrevent 2010 Fatal versus total events in risk assessment models Pekka Jousilahti, MD, PhD,Research Professor National Institute for Health and Welfare, Finland Risk assessment models Estimates the
More informationLecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors
Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life
More informationSmoking and Mortality: New Evidence from a Long Panel. Michael Darden, Donna B. Gilleskie, and Koleman Strumpf 1. August 2017.
Smoking and Mortality: New Evidence from a Long Panel Michael Darden, Donna B. Gilleskie, and Koleman Strumpf 1 August 2017 Abstract Many public health policies are rooted in findings from medical and
More informationClinical Recommendations: Patients with Periodontitis
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;
More informationWine Drinking and Risks of Cardiovascular Complications After Recent Acute Myocardial Infarction
Wine Drinking and Risks of Cardiovascular Complications After Recent Acute Myocardial Infarction Michel de Lorgeril, MD; Patricia Salen, BSc; Jean-Louis Martin, PhD; François Boucher, PhD; François Paillard,
More informationCONTRIBUTING FACTORS FOR STROKE:
CONTRIBUTING FACTORS FOR STROKE: HYPERTENSION AND HYPERCHOLESTEROLEMIA Melissa R. Stephens, MD, FAAFP Associate Professor of Clinical Sciences William Carey University College of Osteopathic Medicine LEARNING
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationHypertension and cardiovascular risk factors: intervention by the family physician
Hypertension and cardiovascular risk factors: intervention by the family physician Hypertension is a common presentation and a known risk factor for cardiovascular disease. L H MABUZA MB ChB, BTh, MFamMed
More informationSetting The setting was primary care. The economic study was carried out in the UK.
Cost-effectiveness of rosuvastatin, atorvastatin, simvastatin, pravastatin and fluvastatin for the primary prevention of CHD in the UK Davies A, Hutton J, O'Donnell J, Kingslake S Record Status This is
More information10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor
Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure
More informationAlcohol and Cancer: Defining the Exposure and Key Milestones in Establishing the Relationship
Alcohol and Cancer: Defining the Exposure and Key Milestones in Establishing the Relationship Susan M. Gapstur, PhD, MPH Vice President, Epidemiology American Cancer Society 1 Disclosure Information SUSAN
More informationFramingham Heart Study Longitudinal Data Documentation
Framingham Heart Study Longitudinal Data Documentation The Framingham Heart Study is a long term prospective study of the etiology of cardiovascular disease among a population of free living subjects in
More informationIschemic Heart Disease Mortality, Morbidity and Risk Factors of Coronary Care Unit Patients
Ischemic Heart Disease Mortality, Morbidity and Risk Factors of Coronary (MBCHB, DM, FICMS) 1 Abstract Background: Ischemic heart disease (IHD) is the commonest type of heart disease.it causes more deaths
More information2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary
2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth
More informationDyslipidemia in the light of Current Guidelines - Do we change our Practice?
Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease
More informationAHEAD - WAVE SECTION B - HEALTH - PAGE 6
AHEAD - WAVE 1-1993 - SECTION B - HEALTH - PAGE 6 B1. Next I have some questions about your health. Would you say your health is excellent, very good, good, fair, or poor? 1.EXCELLENT 2.VERY GOOD 3.GOOD
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationThe value of stratified economic analysis in cohort-level models: A case study on interventions for obstructive sleep apnea
The value of stratified economic analysis in cohort-level models: A case study on interventions for obstructive sleep apnea BERNICE TSOI AND KAREN LEE CADTH Disclosure No actual or potential conflict of
More information7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)
University Pharmacy 5254 Anthony Wayne Drive Detroit, MI 48202 (313) 831-2008 Be able to identify the signs of a heart attack or stoke Identify what puts you at a higher risk for cardiovascular disease,
More informationDrinking over the life-course and health effects. Annie Britton Alcohol Lifecourse Project University College London
Drinking over the life-course and health effects Annie Britton Alcohol Lifecourse Project University College London CLOSER 22 nd March 2018 H H H C C O H H H The UK Medical Research Council Alcohol Research
More informationLEADER Liraglutide and cardiovascular outcomes in type 2 diabetes
LEADER Liraglutide and cardiovascular outcomes in type 2 diabetes Presented at DSBS seminar on mediation analysis August 18 th Søren Rasmussen, Novo Nordisk. LEADER CV outcome study To determine the effect
More informationHIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES
HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused
More informationLipid Management 2013 Statin Benefit Groups
Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date
More informationNorthwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?
Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA Senior Associate Dean Chair, Department of Preventive
More informationSDHU Population Health Profile. Summary Report
SDHU Population Health Profile Summary Report Sudbury & District Health Unit Revised: January 29, 2016 Authors Michael King, Epidemiologist Dar Malaviarachchi, Epidemiologist Alissa Palangio, Data Analyst
More informationIs Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea
Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Hyuncheol Bryant Kim 1, Suejin A. Lee 1, and Wilfredo Lim 2 1 Cornell University
More informationType of intervention Primary prevention; secondary prevention. Economic study type Cost-effectiveness analysis and cost utility analysis.
A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients Milne R J, Hoorn S V, Jackson R T Record
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationTennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center
Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center 2006 Tennessee Department of Health 2006 ACKNOWLEDGEMENTS CONTRIBUTING
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationSmoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study
European Heart Journal (24) 25, 49 45 Clinical research Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study Abdullah
More informationSupplementary Online Content
Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.
More informationCardiovascular Disease
Cardiovascular Disease Chapter 15 Introduction Cardiovascular disease (CVD) is the leading cause of death in the U.S. One American dies from CVD every 33 seconds Nearly half of all Americans will die from
More informationEssential Hypertension Management Considerations By Elaine Lewis, ND
Essential Hypertension Management Considerations By Elaine Lewis, ND Elaine Lewis, ND Research Resident, Canadian College of Naturopathic Medicine 1255 Sheppard Avenue East North York, Ontario Back To
More informationBiases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University
Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of
More informationCardiovascular Diseases and Diabetes
Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular
More informationAnalyzing diastolic and systolic blood pressure individually or jointly?
Analyzing diastolic and systolic blood pressure individually or jointly? Chenglin Ye a, Gary Foster a, Lisa Dolovich b, Lehana Thabane a,c a. Department of Clinical Epidemiology and Biostatistics, McMaster
More informationWhat s new in cardiovascular disease risk assessment and management for primary care clinicians
Cardiovascular system What s new in cardiovascular disease risk assessment and management for primary care clinicians The recently released 2018 Cardiovascular Disease Risk Assessment and Management for
More informationSEX LIES CHOLESTEROL
SEX LIES and the CHOLESTEROL What You Don t Know Could Hurt You! TRUTH about Cardiovascular Disease Statistics Estimates for the year 2006 are that 81,100,000 people in the United States have one or more
More informationComprehensive Tobacco Control Programs: Economic Review. Page 1 of 26. Study Info Intervention Characteristics Population Characteristics
Study Info Intervention Characteristics Population Characteristics Author, Year: Carter, 2000 Study design: Cost-effectiveness analysis Perspective: Commonwealth and Healthcare sector Location: Australia
More informationModerate alcohol consumption is associated with decreased
Alcohol Consumption and Plasma Concentration of C-Reactive Protein Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Moderate alcohol intake has been associated with
More informationComparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study
80 Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study Thomas Truelsen, MB; Ewa Lindenstrtfm, MD; Gudrun Boysen, DMSc Background and Purpose We wished to
More informationComparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes
Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes Joshua A Salomon, Anushka Patel, Bruce Neal, Paul Glasziou, Diederick E. Grobbee,
More informationIntermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis
Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which
More informationHeart Disease and Stroke Statistics 2010 Update. 2009, American Heart Association. All rights reserved.
Heart Disease and Stroke Statistics 21 Update Questions on statistics? mailto:nancy.haase@heart.org Audio-visual questions? mailto:david.brentz@heart.org Please keep the red wave and logo attached to these
More informationORIGINAL INVESTIGATION. Lifestyle and 15-Year Survival Free of Heart Attack, Stroke, and Diabetes in Middle-aged British Men
ORIGINAL INVESTIGATION Lifestyle and 15-Year Survival Free of Heart Attack, Stroke, and Diabetes in Middle-aged British Men S. Goya Wannamethee, PhD; A. Gerald Shaper, FRCP; Mary Walker, MA; Shah Ebrahim,
More informationAn update on lipidology and cardiovascular risk management. Lipids, Metabolism & Vascular Risk Section - Royal Society of Medicine
An update on lipidology and cardiovascular risk management Lipids, Metabolism & Vascular Risk Section - Royal Society of Medicine National and international lipid modification guidelines: A critical appraisal
More informationRisk modeling for Breast-Specific outcomes, CVD risk, and overall mortality in Alliance Clinical Trials of Breast Cancer
Risk modeling for Breast-Specific outcomes, CVD risk, and overall mortality in Alliance Clinical Trials of Breast Cancer Mary Beth Terry, PhD Department of Epidemiology Mailman School of Public Health
More informationAlbany County Health Profile
7/22/215 Albany County Health Profile Prepared By: www.hcdiny.org General Health: Albany Capital NYS, PA 217 County # Indicator Year(s) County Region except NYC Objective change needed For rate/% Rate/%
More informationAlcohol Consumption and Mortality in Serbia: Twenty-year Follow-up Study
45(6):764-768,2004 PUBLIC HEALTH Alcohol Consumption and Mortality in Serbia: Twenty-year Follow-up Study Branko Jakovljeviæ, Vesna Stojanov 1, Katarina Paunoviæ, Goran Belojeviæ, Nataša Miliæ 2 Institute
More informationlyondellbasell.com Managing Hypertension
Managing Hypertension Managing Hypertension There is a growing evidence that the good health of your heart and circulation will help you to age more successfully. A man is as old as his arteries Thomas
More informationExamining the relationship between beverage intake and cardiovascular health. Ian Macdonald University of Nottingham UK
Examining the relationship between beverage intake and cardiovascular health Ian Macdonald University of Nottingham UK Outline Assessment of evidence in relation to health risks of dietary components Cardiovascular
More informationLogistic Regression Predicting the Chances of Coronary Heart Disease. Multivariate Solutions
Logistic Regression Predicting the Chances of Coronary Heart Disease Multivariate Solutions What is Logistic Regression? Logistic regression in a nutshell: Logistic regression is used for prediction of
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationProbabilistic Models for Heart Disease and Related Conditions
, July 5-7, 2017, London, U.K. Probabilistic Models for Heart Disease and Related Conditions Y. S. Yusoff., G Streftaris, H. R. Waters Abstract The mortality rates in the UK has changed over time. The
More informationHEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.
OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY THE OREGON DEPARTMENT OF HUMAN SERVICES HEALTH SERVICES HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM www.healthoregon.org/hpcdp Contents
More informationI t is well established that non-insulin dependent diabetes is
1398 CARDIOVASCULAR MEDICINE Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease S G Wannamethee, A G Shaper, L Lennon... See end of article
More informationSupplementary Online Content
Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic
More informationANNUAL FOLLOW-UP QUESTIONNAIRE
SLEEP HEART HEALTH STUDY - TUCSON ANNUAL FOLLOW-UP QUESTIONNAIRE - 2003 Dear Sleep Heart Health Study participant: Today s Date: / / Month Day Year Please take the time to complete and return this short
More informationPage down (pdf converstion error)
1 of 6 2/10/2005 7:57 PM Weekly August6, 1999 / 48(30);649-656 2 of 6 2/10/2005 7:57 PM Achievements in Public Health, 1900-1999: Decline in Deaths from Heart Disease and Stroke -- United States, 1900-1999
More informationDate: / / Hello, my name is [interviewer name], and I'm calling to speak with [participant name]. Is [participant name] available?
Multi-Ethnic Study of Atherosclerosis Follow-up Phone Call 16 Participant Id#: Acrostic: General Health Date: / / Day INTRODUCTION Hello, my name is [interviewer name], and I'm calling to speak with [participant
More informationThe Muscatine Study Heart Health Survey
The Muscatine Study Heart Health Survey PARTICIPANT ID LABEL (include study ID, name, DOB, gender) Today s Date: - - (MM-DD-YYYY) Thank you for agreeing to participate in the International Childhood Cardiovascular
More informationCommon Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2
Established CVD Common Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2 Primary and Secondary Diagnosis Codes Primary Diagnosis: Primary hyperlipidemia
More informationMediterranean Diet, Lifestyle Factors, and 10-Year Mortality -The HALE project-
Mediterranean Diet, Lifestyle Factors, and 10-Year Mortality -The HALE project- Kim Knoops PhD-Student Wageningen University Supervisors: W.A. van Staveren C.P.G.M. de Groot D. Kromhout Outline of the
More informationModelling Reduction of Coronary Heart Disease Risk among people with Diabetes
Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made
More informationSupplementary Online Content
Supplementary Online Content Den Ruijter HM, Peters SA, Anderson TJ, et al. Common carotid intimamedia thickness measurements in cardiovascular risk prediction. JAMA. doi:10.1001/jama.2012.9630. etable
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationDate: / / Hello, my name is [interviewer name], and I'm calling to speak with [participant name]. Is [participant name] available?
Multi-Ethnic Study of Atherosclerosis Follow-up Phone Call 17 Participant Id#: Acrostic: General Health Date: / / Day INTRODUCTION Hello, my name is [interviewer name], and I'm calling to speak with [participant
More informationAlcohol s Good for You? Some Scientists Doubt It
Alcohol s Good for You? Some Scientists Doubt It By RONI CARYN RABIN Published: June 15, 2009 Pier Paolo Cito/Associated Press New York Times, Online Edition, June 15, 2009. A version of this article appeared
More informationINTEGRATED CHRONIC DISEASE PREVENTION
INTEGRATED CHRONIC DISEASE PREVENTION What Is Integrated Health Promotion? In this context, the term integrated health promotion refers to an approach to health and wellbeing that acknowledges that risk
More information5. Cardiovascular Disease & Stroke
5. Cardiovascular Disease & Stroke 64: Self-Reported Heart Disease 66: Heart Disease Management 68: Heart Disease Mortality 70: Heart Disease Mortality Across Life Span 72: Stroke Mortality 185: Map 3:
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationAppendix S1. List of Figures. List of Tables
Appendix S1 List of Figures S1 Comparison of death rates in RealAge sample to US death rates...................... 1 S2 RealAge delta in California sample with full identifiers..........................
More informationTEN-YEAR ABSOLUTE RISK ESTImates
ORIGINAL CONTRIBUTION CLINICIAN S CORNER Lifetime Risk and Years Lived Free of Total Cardiovascular Disease Scan for Author Video Interview John T. Wilkins, MD, MS Hongyan Ning, MD, MS Jarett Berry, MD,
More informationUlster, Ireland. Submitted: 21 June 2009; Revised: 24 January 2010; Published: 13 September 2010 Petrazzuoli F, Soler JK, Buono N, Dobbs F
O R I G I N A L R E S E A R C H Quality of care for hypertensive patients with type 2 diabetes in a rural area of Southern Italy: is the recording of patient data and the achievement of quality indicators
More informationVascular Diseases. Overview: Selected Slides
Vascular Diseases Overview: Selected Slides Total deaths and change in vascular death rates
More informationFY 2011 WISEWOMAN Approved ICD-9 Code List
243 Congenital hypothyroidism 245.0 Thyroiditis; Acute thyroiditis 245.1 Thyroiditis; Subacute thyroiditis 245.2 Thyroiditis; Chronic lymphocytic thyroiditis 245.3 Thyroiditis; Chronic fibrous thyroiditis
More information1. The table shows the results of a blood test carried out on a patient who had suffered a heart attack. All units are arbitrary units.
1. The table shows the results of a blood test carried out on a patient who had suffered a heart attack. All units are arbitrary units. Substance Concentrations in patient s blood Normal range Cholesterol
More informationOriginal Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit
98 Original Contributions Prospective Comparison of a Cohort With Carotid Bruit and a Population-Based Cohort Without Carotid Bruit David O. Wiebers, MD, Jack P. Whisnant, MD, Burton A. Sandok, MD, and
More informationTable S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis
SUPPLEMENTARY MATERIAL TEXT Text S1. Multiple imputation TABLES Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis Table S2. List of drugs included as immunosuppressant
More informationDevelopment and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
open access Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study Julia Hippisley-Cox, 1 Carol Coupland, 1 Peter Brindle
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationTable Cohort studies of consumption of alcoholic beverages and cancer of the colorectum
Akhter et al. (2007), Japan, Miyagi Study [data also included in the pooled analysis, Mizoue et al. (2008)] of 21 199 men living in the Miyagi region recruited in 1990; aged 40 64 years; followed-up until
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Peripheral arterial disease Potential output:
More informationThe Gender Divide Women, Men and Heart Disease February 2017
The Gender Divide Women, Men and Heart Disease February 2017 Nandita S. Scott, MD FACC Co-Director MGH Heart Center Corrigan Women s Heart Health Program Massachusetts General Hospital Heart Disease For
More informationResearchers prefer longitudinal panel data
Pseudo-panel approach for repeated cross-sectional data - an introduction Yang Meng Sheffield Alcohol Research Group School of Health and Related Research University of Sheffield Researchers prefer longitudinal
More information9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.
UW MEDICINE UW MEDICINE UCSF ASIAN TITLE HEALTH OR EVENT SYMPOSIUM 2017 DISCLOSURES Consultant: RubiconMD ESTIMATING CV RISK IN ASIAN AMERICANS AND PREVENTION OF CVD Research: Amgen, NHLBI EUGENE YANG,
More informationrosuvastatin, 5mg, 10mg, 20mg, film-coated tablets (Crestor ) SMC No. (725/11) AstraZeneca UK Ltd.
rosuvastatin, 5mg, 10mg, 20mg, film-coated tablets (Crestor ) SMC No. (725/11) AstraZeneca UK Ltd. 09 September 2011 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product
More informationRecent developments in mortality
Recent developments in mortality Richard Willets Willets Consulting Recent developments in mortality Patterns of aggregate mortality change Underlying causes Heart disease Lung cancer Other cancers Patterns
More information